Thornton & Ross
Welcome To Thornton & Ross.
- Healthcare
| GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 7 % | (6 %) | 4 % | 40 % | 24 % | (6 %) | 3 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 38 % | 16 % | 19 % | 19 % | 16 % | 13 % | 14 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 29 % | 8 % | 11 % | 9 % | 7 % | 2 % | 7 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Thornton & Ross was founded in 1922 by Nathan Thornton and Phillip Ross in Linthwaite, Huddersfield. The company started as a small pharmaceutical manufacturer, navigating the challenging economic climate of the 1920s. By 1926, they had grown to employ 10 people, laying the foundation for future expansion.
Over the decades, Thornton & Ross became known for producing over-the-counter (OTC) pharmaceutical products, including popular brands like Covonia cough medicine and Zoflora disinfectant. The company steadily expanded its reach, exporting products to over 80 countries worldwide.
A significant milestone in the company's history occurred in 2013 when Thornton & Ross was acquired by the German pharmaceutical company STADA AG. The acquisition, valued at approximately 259 million euros, marked a new chapter for Thornton & Ross, providing them with the resources and support to further expand their product offerings and market presence.
Today, Thornton & Ross continues to thrive as part of STADA AG, maintaining its reputation as a leading manufacturer of OTC pharmaceuticals in the UK. The company's journey from a small local business to a key player on the global stage is a testament to its enduring commitment to quality and innovation in healthcare.